News & Articles

New generation of bioreactors combined with new Flexsafe STR® bags offer a fully scalable, single-use system

Discover how this game-changing instrument will impact the field and hear about the challenges in developing the next generation of automation technology

Glythera gains exclusive access to Cancer Research UK’s novel CDK11 inhibitor programme for the development of antibody drug conjugates

Program is 'invaluable' for scientists needing to make informed purchasing decisions for their lab

New modular membrane chromatography solution for large-scale applications

Kit increases efficiency of residual protein A ligand detection

Fully scalable system streamlines drug development and production with sizes ranging from 3-liter bench-top to 1000-liter manufacturing scale

AEOL 10150 is currently the only drug being developed by BARDA to address the delayed effects of radiation exposure

Enhanced biomolecular characterization platform expands assay capabilities for biologics and small molecule characterization, increasing data access and quality